Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Vedere Bio, Inc.

Vedere is developing cutting-edge gene therapy products to restore functional vision to patients who have suffered vision loss from Inherited Retinal Degenerations (IRDs), as well as other causes of both genetic and non-genetic vision loss. While the vast majority of ocular gene therapies only limit the rate of inevitable vision loss, we aim to restore lost vision regardless of a patient’s underlying genetics or their stage of disease.

238 space logo Vedere Bio, Inc. logo
Website - Coming Soon
  • Xiaozhi Ren Associate Director
  • Chris Brown Principal Research Associate
  • Yonatan Abune Principal Research Associate
  • Anna Prendeville Senior Research Associate
  • Tushar Patel Associate Director Analytical Development
  • Yanjing Li Scientist II
  • Nicholas Gentile Downstream Process Development
  • Varick Ho Research Associate
  • Shreya Kaul Upstream Process Development
  • Matthew Maderia Research Associate II
  • John Emmett Research Associate II